Right Drug, Right Dose, Right Time – Using Genomic Data to Individualize Treatment

Overview

Información sobre este estudio

This research is being done to better understand how genetic information related to drug dosing and use can affect medical care of patients.

This study is asking to allow access to stored blood sample in the Mayo Clinic Biobank (IRB#08-007049) so researchers can study DNA to find out if genetic variants that play a role in how the body responds to certain drugs, primarily prescription drugs. In this study, we are interested in genetic variants that may affect whether some people:

• need a lower or higher dose of a drug

• are at an increased risk of side effects to a drug

• should avoid certain drugs

By doing this study, we are developing and improving ways to incorporate information about drug related genetic variants into the medical record. Some information about your genetic variants will be put into your medical record to guide your clinical care. Furthermore, we hope to identify new genetic variants related to how people’s bodies respond to drugs.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  1. Enrolled in the Mayo Clinic Biobank (IRB # 08:0007049)
  2. Olmsted County or resident of a surrounding area.
  3. Assigned to receive primary care from a clinician in one of the Internal Medicine Clinics (Primary Care Internal Medicine, Family Medicine, etc.)
  4. Has had an office visit within 5 years of the date of selection
  5. Likely to be on drugs of interest in one to 3 years of date of selection
  6. Able to provide informed consent

Exclusion Criteria:

  1. Institutionalized (i.e., Federal Medical Prison)

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Suzette Bielinski, Ph.D., M.Ed.

Cerrado para la inscripción

Contact information:

Tricia Lindstrom

(507) 284-2843

Lindstrom.Tricia@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20316196

Mayo Clinic Footer